Blood cancer Clinical Trials in Aurora, CO

As of August 2026, 47 paid clinical trials are recruiting for Blood cancer in Aurora, Colorado. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 27, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

48 clinical trials for Blood cancer

·Clear filters·

Email me when a new blood cancer trial opens in Aurora, CO.

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

for Hematopoietic and Lymphoid Cell Neoplasm

Sites in Aurora +27 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 2 - 18

Code: NCT05711667·Phase 3·Recruiting·Listed Feb 2023

Apply to this trial

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

for Hematopoietic and Lymphatic System Neoplasm

Sites in Aurora +75 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 15 - 20

Code: NCT06410209·Phase 2·Recruiting·Listed May 2024

Apply to this trial

Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families

for Leukemia

1 location in Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: Up to 22

Code: NCT05425992·Recruiting·Listed Jun 2022

Apply to this trial

UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1

for Acute Lymphoid Leukemia

1 location in Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 18+

Code: NCT05535855·Phase 1·Recruiting·Listed Sep 2022

Apply to this trial

Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

for Leukemia

Drug: Venetoclax

1 location in Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 80

Code: NCT06429449·Phase 1·Recruiting·Listed May 2024

Apply to this trial

CC-486 and Venetoclax for Acute Myeloid Leukemia

for AML

Drug: Venetoclax

2 locations in Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 100

Code: NCT05287568·Phase 1·Recruiting·Listed Mar 2022

Apply to this trial

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for Multiple Myeloma

Drug: Belantamab mafodotin

Sites in Aurora +29 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06679101·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Conditions in Blood cancer (Aurora, CO)

Acute myeloid leukemia (AML)· 14 Non-Hodgkin lymphoma· 13 Hematologic malignancy· 8 Leukemia (other)· 7 Chronic lymphocytic leukemia (CLL)· 6 Myelodysplastic syndromes (MDS)· 5 Multiple myeloma· 4 Acute lymphoblastic leukemia· 4 Hodgkin lymphoma· 4 Myelofibrosis· 3 Myeloproliferative neoplasm· 3 Diffuse large B-cell lymphoma (DLBCL)· 3 Follicular lymphoma· 2 Small lymphocytic lymphoma· 2 Burkitt lymphoma· 2 Mantle cell lymphoma· 1 Marginal zone lymphoma· 1